ArisGlobal launches LifeSphere Regulatory platform

By Jenni Spinner

- Last updated on GMT

(ipopba/iStock via Getty Images Plus)
(ipopba/iStock via Getty Images Plus)

Related tags Data management Drug development Software Cloud software

The drug development software specialist has introduced technology designed to streamline regulatory information management.

ArisGlobal, a producer of software solutions geared toward automation of core drug development functions for global life sciences companies, has introduced LifeSphere Regulatory. The cloud-based platform is designed to help users handle their entire regulatory management process in one integrated suite.

The platform consists of two key parts. The LifeSphere RIMS component is engineered to manage core regulatory processes. LifeSphere Publishing is a submissions management system that reportedly lets  life-science organizations compile, publish, and validate regulatory submissions with support for all major global eCTD requirements.

The LifeSphere Regulatory platform also is integrated with LifeSphere EasyDocs, a cloud document management platform that provides a single source of reference for data and documents across research and development (R&D) business processes.

Pratyusha Pallavi, head of regulatory product Management at ArisGlobal, said handling regulatory issues can be a formidable challenge for many life-science organizations.

Regulatory teams face many challenges, including keeping global teams aligned, managing growing regulatory complexity, and siloed information that slows the R&D process​,” Pallavi said. “LifeSphere Regulatory solves these challenges by providing an intuitive and flexible suite that’s focused on risk reduction, collaboration, and efficiency​.”

According to the company, LifeSphere Regulatory is built to provide efficiency through automation capabilities, as well as an approach that allows regulatory tasks to be handled in one simple interface. The platform reduces risk and stays up to date with the latest regulations via modern cloud architecture that delivers free upgrades and future-proof compliance. Notably, unlike other RIMS applications, LifeSphere Regulatory comes Identification of Medicinal Products (IDMP)-ready.

Giving key stakeholders across an organization access to the same documents and data reportedly helps keep teams around the world aligned. The company reports the LifeSphere Regulatory platform enables teams to work together without having to resort to time-resuming workarounds.

Learn more about LifeSphere Regulatory here​, and about LifeSphere EasyDocs​ here. 

DIA 2020 presentations

ArisGlobal will be presenting at two sessions during DIA 2020

  • Leveraging Automation in PV​, Monday June 15th at 10:15 am: Emmanuel Belabe, associate vice president of safety at ArisGlobal will walk attendees through a view of how organizations are approaching and implementing automation.
  • The Evolving Role of CTMS in Risk Management​, Tuesday June 16, 10:45 am: ArisGlobal’s senior director of clinical Sondra Pepe will explore how the CTMS footprint is evolving with the advent of a quality by design approach to clinical operations.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Related suppliers

Follow us


View more